GENEVA/ZURICH - Health officials reviewing Gilead Science Inc's remdesivir against COVID-19 should consider all evidence, including a trial where the medicine failed, before giving it the green light, the top WHO scientist said on Friday.
The FDA decision came a week after the release of the results of the World Health Organization's Solidarity trial, which concluded remdesivir has little or no impact on a patient's chances of surviving COVID-19. Gilead's own study, of 1,062 participants, produced data indicating that the treatment cut COVID-19 recovery time by five days and helped reduce the risk of death in some patients who were getting oxygen.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Philippines Latest News, Philippines Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Gilead’s remdesivir gets US FDA approval for use in hospitalized COVID-19 patientsThe U.S. Food and Drug Administration on Thursday approved Gilead Sciences Inc&039;s antiviral drug remdesivir for treating patients hospitalized with COVID-19, making it the first and only drug
Source: inquirerdotnet - 🏆 3. / 86 Read more »
FDA approves first Covid-19 drug: antiviral remdesivirUS REGULATORS approved on October 22 the first drug to treat Covid-19: remdesivir, an antiviral medicine given to hospitalized patients through an...
Source: sunstaronline - 🏆 18. / 59 Read more »
Gilead's remdesivir gets U.S. FDA approval for hospitalized COVID-19 patientsThe U.S. Food and Drug Administration on Thursday approved Gilead Sciences Inc’s antiviral drug remdesivir for treating patients hospitalized with COVID-19, making it the first and only drug approved for the disease in the United States. Remdesivir, given intravenously, was one of the drugs used to treat U.S. President Donald Trump during his bout with …
Source: interaksyon - 🏆 24. / 51 Read more »
First large-scale US COVID-19 vaccine trial reaches target enrollment of 30,000 participantsModerna, the first company to start US clinical trials of a COVID-19 vaccine, finished enrolling all 30,000 of its participants.
Source: CNN Philippines - 🏆 13. / 63 Read more »
No new COVID-19 deaths in Central Visayas on Oct. 22CDNTopStories Central Visayas recorded another day without new mortalities related to the coronavirus disease 2019 (COVID-19). Read more: CDNDigital
Source: cebudailynews - 🏆 8. / 71 Read more »
13 detainees positive for COVID-19 in rapid test escape jail facility in CaloocanBREAKING: 13 detainees escaped from the Caloocan Police Station's temporary detention facility early this morning. Based on security camera footage, the escapees passed through a small hole in their cell. JUST IN: The 13 Caloocan jail escapees tested positive for COVID-19 via rapid test, Caloocan Police Chief Col. Dario Menor confirms Please spread their names and faces asap. hahahaha
Source: CNN Philippines - 🏆 13. / 63 Read more »